Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

The randomized controlled double-blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on the cardiac function of long COVID patients

News | Coronavirus (COVID-19)

Oxygen Therapy Improves Heart Function in Patients with Long COVID

May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy ...

May 10, 2023

This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases

News | Womens Cardiovascular Health

Women are Underrepresented in Cardiovascular Clinical Trials

May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials ...

May 10, 2023

News | Heart Valve Technology

Edwards' Aortic Valve with Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in 7-year Data

May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structu ...

May 09, 2023

This recent advance fulfils the requirements needed to promote an efficient translation of innovations and new treatments from the bench to the bedside in this field

News | Stroke

New Reproducible and Minimally Invasive Stroke Model Through an Endovascular Approach

May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol ...

May 08, 2023

72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.

News | Computed Tomography (CT)

Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption

May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high ...

May 05, 2023

This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval

News | Drug-Eluting Balloons

MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

May 4, 2023 — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the Ca ...

May 04, 2023

Investigators are one step closer to achieving this breakthrough in preventive healthcare and offering patients personalized predictions of their heart health thanks to a novel deep-learning tool and artificial intelligence (AI) algorithm developed at Cedars-Sinai.

News | Artificial Intelligence

New AI Tool Developed at Cedars-Sinai Can Predict Adverse Cardiac Events Like Heart Attacks, and Show How Risk Changes Over Time

May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or ...

May 04, 2023

A new book written by and for interventional cardiologists provides a collection of detailed case studies, clinical data and imagery, according to Cedars-Sinai, whose team from Smidt Heart Institute is among the editors of the publication.

Feature | Cardiovascular Education | Christine Book

Book Offering Collection of Complex Interventional Cardiology Cases Published by Team from Cedars-Sinai Smidt Heart Institute

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute a ...

May 04, 2023

A team led by researchers at The University of Texas at Austin has developed an ultrathin, lightweight electronic tattoo, or e-tattoo, that attaches to the chest for continuous, mobile heart monitoring outside of a clinical setting

News | Wearables

Chest e-Tattoo Boasts Major Improvements in Heart Monitoring

May 3, 2023 — A new flexible, wearable medical device could provide a major boost in the fight against heart disease ...

May 03, 2023

Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP Platform

News | EP Device Monitoring Systems

BioSig to Highlight New Data from the PURE EP Platform at Heart Rhythm 2023

May 3, 2023 — BioSig Technologies, Inc., a medical technology company delivering unprecedented accuracy and precision to ...

May 03, 2023

MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end

News | Pharmaceuticals

Sequana Medical Announces FDA Clearance of IND Application for DSR 2.0 for Treatment of Congestive Heart Failure

May 2, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

May 02, 2023

Procedure performed as part of the company’s ongoing CGuardians U.S. Investigational Device Exemption (IDE) trial designed to support potential U.S. marketing approval of the CGuard stent system

News | Stents Carotid

InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform

May 1, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

May 01, 2023

The results of a long-term analysis show necessary adjustments in international guidelines as well as in diagnosis and treatment

News | Cardiogenic Shock

Windtree Therapeutics Announces Publication from Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime

April 28, 2023 — Windtree Therapeutics, Inc. is a biotechnology company focused on advancing late-stage interventions ...

April 28, 2023

A first-of-its-kind study has compared artery stiffness in participants pre and post-COVID-19 infection

News | Coronavirus (COVID-19)

Study Suggests Mild COVID-19 Can Have Harmful Effects on Cardiovascular Health

April 27, 2023 — New research suggests that even mild cases of COVID-19 can have long-term detrimental effects on ...

April 27, 2023

The platform, EchoGo Amyloidosis, uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis, a condition caused by deposits of abnormal proteins in the heart tissue, using only a single commonly acquired ultrasound view of the heart.

News | Coronavirus (COVID-19)

Ultromics Granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis Detection

April 27, 2023 — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has ...

April 27, 2023